In the latest trading session, Oscar Health, Inc. (OSCR) closed at $12.21, marking a +1.5% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.54%. Elsewhere, the Dow saw an upswing of 0.66%, while the tech-heavy Nasdaq appreciated by 0.77%. The company's shares have seen a decrease of 2.2% over the last month, surpassing the Finance sector's loss of 5.77% and the S&P 500's loss of 4.71%.The upcoming earnings release of Oscar Health, Inc. will be of great interest to i ...

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $13.30, marking a -1.92% move from the previous day. The stock's change was less than the S&P 500's daily loss of 0.28%. Meanwhile, the Dow lost 0.44%, and the Nasdaq, a tech-heavy index, lost 0.28%. Prior to today's trading, shares of the company had lost 1.02% was narrower than the Finance sector's loss of 6.73% and the S&P 500's loss of 3.59%.Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. ...

Lemonade (LMND) shares soared 15.8% in the last trading session to close at $66.87. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 9.4% loss over the past four weeks.Lemonade has broadened its business beyond renters and homeowners insurance by expanding into auto insurance through the Metromile acquisition, as well as pet and life coverage. This diversification strengthens its revenue base and reduces dependence on any single p ...

Company Performance - Hamilton Insurance closed at $29.08, reflecting a +1.61% increase from the previous day, outperforming the S&P 500 which fell by 0.61% [1] - Over the past month, shares of Hamilton Insurance have decreased by 7.71%, underperforming the Finance sector's decline of 5.63% and the S&P 500's loss of 2.25% [1] Upcoming Earnings - The company is expected to report an EPS of $1.02, representing a 117.02% increase compared to the same quarter last year [2] - Revenue is anticipated to be $678.96 million, indicating an 11.68% decrease from the same quarter of the previous year [2] Full Year Estimates - For the full year, analysts project earnings of $3.42 per share and revenue of $2.83 billion, reflecting changes of -29.34% and -2.53% respectively from last year [3] - Recent changes to analyst estimates suggest a trend of optimism regarding the company's near-term business performance [3] Analyst Ratings - The Zacks Rank system currently rates Hamilton Insurance at 4 (Sell), with a recent downward shift of 11.4% in the consensus EPS estimate over the past month [5] - The Zacks Rank has a history of outperforming, with 1 rated stocks returning an average annual gain of +25% since 1988 [5] Valuation Metrics - Hamilton Insurance is trading with a Forward P/E ratio of 8.37, which is lower than the industry's Forward P/E of 9.13, indicating a valuation discount [6] - The Insurance - Multi line industry is ranked 147 in the Zacks Industry Rank, placing it in the bottom 40% of over 250 industries [6]

Core Viewpoint - Prudential Financial, Inc. reported mixed fourth-quarter results, with adjusted operating income missing estimates but revenues exceeding expectations, leading to a 3.3% decline in shares since the last earnings report [1][3][15]. Financial Performance - Adjusted operating income for Q4 2025 was $3.30 per share, missing the Zacks Consensus Estimate by 2%, but reflecting an 11.5% year-over-year increase [3]. - Total revenues reached $14.52 billion, marking an 11.6% increase year-over-year and beating the Zacks Consensus Estimate by 6% [4]. - Total benefits and expenses were $13 billion, up 11.8% year-over-year, driven by higher insurance and annuity benefits [5]. Segment Performance - Prudential Global Investment Management (PGIM) reported adjusted operating income of $249 million, a decrease of 3.8% year-over-year due to higher expenses [6]. - PGIM's assets under management increased by 7% year-over-year to $1.466 trillion, supported by equity market appreciation [7]. - The U.S. Businesses segment delivered an adjusted operating income of $1 billion, up 22% year-over-year, attributed to favorable underwriting results [7]. - International Businesses' adjusted operating income rose 2% year-over-year to $757 million, driven by improved net investment spread results [8]. - Corporate and Other segment incurred an adjusted operating loss of $552 million, wider than the previous year's loss of $490 million [9]. Capital Deployment - Prudential returned $730 million to shareholders through share repurchases and dividends in Q4 [10]. - The board authorized a 4% increase in the quarterly cash dividend to $1.40 per share, marking the 18th consecutive year of dividend increases [11]. Financial Update - Cash and cash equivalents at the end of Q4 were $19.7 billion, a 6.5% increase from the end of 2024 [13]. - Total debt increased by 0.7% to $20.3 billion [13]. - Adjusted book value per common share was $100.17, reflecting a 4.5% year-over-year increase [14]. Full-Year Update - For 2025, adjusted operating income was $14.43 per share, a 14.3% increase from 2023, but missed estimates by 0.4% [15]. - Total revenues for the year were $57.6 billion, down 15% from 2024, but exceeded estimates by 0.9% [15]. Market Outlook - Estimates for Prudential have been trending downward, indicating a potential in-line return in the coming months, with a Zacks Rank of 3 (Hold) [18].

Core Viewpoint - Investors in Prudential Financial, Inc. (PRU) should closely monitor the stock due to significant implied volatility in the options market, particularly for the March 20, 2026 $47.5 Put option [1] Company Analysis - Prudential Financial currently holds a Zacks Rank of 3 (Hold) within the Insurance - Multi line industry, which is positioned in the top 36% of the Zacks Industry Rank [3] - Over the past 60 days, no analysts have increased earnings estimates for the current quarter, while two analysts have lowered their estimates, resulting in a decrease of the Zacks Consensus Estimate from $3.50 per share to $3.42 [3] Options Market Insights - The high implied volatility suggests that options traders are anticipating a significant price movement for Prudential Financial shares, indicating potential trading opportunities [4] - Seasoned options traders often seek to sell premium on options with high implied volatility, aiming to benefit from the decay of the option's value if the underlying stock does not move as much as expected [4]

Core Insights - James River Group (JRVR) reported quarterly earnings of $0.3 per share, missing the Zacks Consensus Estimate of $0.31 per share, but showing improvement from a loss of $0.99 per share a year ago [1] - The company posted revenues of $167.75 million for the quarter, missing the Zacks Consensus Estimate by 5.12%, compared to $126.71 million in the same quarter last year [2] - The stock has gained approximately 10.1% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] Earnings Performance - The earnings surprise for the recent quarter was -3.23%, while the previous quarter saw a positive surprise of +23.08% [1][2] - Over the last four quarters, James River Group has surpassed consensus EPS estimates two times [2] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $177.4 million, and for the current fiscal year, it is $1.25 on revenues of $715 million [7] - The estimate revisions trend for James River Group was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Insurance - Multi line industry, to which James River Group belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Core Viewpoint - Oscar Health, Inc. (OSCR) has experienced a stock return of -8.5% over the past month, contrasting with the Zacks S&P 500 composite's +0.6% change, indicating potential challenges ahead for the stock [1] Earnings Estimates - Oscar Health is projected to post earnings of $1.21 per share for the current quarter, reflecting a year-over-year increase of +31.5%, with a significant upward revision of +43.2% in the Zacks Consensus Estimate over the last 30 days [4] - For the current fiscal year, the consensus earnings estimate of $0.2 indicates a remarkable change of +111.8% from the previous year, with a substantial revision of +168.5% in the last month [4] - The consensus earnings estimate for the next fiscal year stands at $1.06, suggesting a change of +430% compared to the prior year, with no changes in the estimate over the past month [5] Revenue Growth - The consensus sales estimate for the current quarter is $4.89 billion, indicating a year-over-year growth of +60.6%, while estimates for the current and next fiscal years are $18.91 billion and $21.16 billion, reflecting increases of +61.6% and +11.9%, respectively [10] Recent Performance and Surprise History - In the last reported quarter, Oscar Health generated revenues of $2.81 billion, marking a year-over-year increase of +17.3%, but reported an EPS of -$1.24, which is a decline from -$0.62 a year ago [11] - The company reported revenues that were -12.49% below the Zacks Consensus Estimate of $3.21 billion, and the EPS surprise was -47.62% [11] - Over the last four quarters, Oscar Health has surpassed consensus EPS estimates three times but only exceeded revenue estimates once [12] Valuation - Oscar Health is graded B in the Zacks Value Style Score, indicating that it is trading at a discount compared to its peers, which suggests potential undervaluation [16]

分组1 - MBIA reported a quarterly loss of $0.24 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.05, and improved from a loss of $0.48 per share a year ago, indicating an earnings surprise of -380.00% [1] - The company posted revenues of $28 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 40.00%, although this was a decrease from year-ago revenues of $29 million [2] - MBIA shares have declined approximately 11.7% since the beginning of the year, contrasting with the S&P 500's gain of 1.5% [3] 分组2 - The earnings outlook for MBIA is uncertain, with current consensus EPS estimates of -$0.11 on $20 million in revenues for the coming quarter and -$0.27 on $77 million in revenues for the current fiscal year [7] - The Zacks Industry Rank indicates that the Insurance - Multi line sector is currently in the bottom 44% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - The estimate revisions trend for MBIA was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6]

分组1 - Octave Specialty Group (OSG) reported a quarterly loss of $0.02 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.21, representing an earnings surprise of +90.24% [1] - The company posted revenues of $66.9 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 20.24%, compared to year-ago revenues of $65.22 million [2] - The stock has underperformed the market, losing about 25.7% since the beginning of the year, while the S&P 500 gained 0.9% [3] 分组2 - The current consensus EPS estimate for the coming quarter is -$0.04 on revenues of $83.46 million, and for the current fiscal year, it is $0.03 on revenues of $338.55 million [7] - The Zacks Industry Rank for Insurance - Multi line is currently in the bottom 40% of over 250 Zacks industries, indicating potential challenges for the stock's performance [8] - Another company in the same industry, James River Group, is expected to report quarterly earnings of $0.31 per share, reflecting a year-over-year change of +131.3% [9]